Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2013

1705  University of Houston  (21183)

Principal Investigator: HUSSAIN,TAHIR

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 319,758

Exceeds $250,000 (Is it flagged?): Yes

Start and End Dates: 9/1/12 <> 8/31/14

Restricted Research: YES

Academic Discipline: PHARMACOLOGICAL & PHARMACEUTIC

Department, Center, School, or Institute: PHARMACY

Title of Contract, Award, or Gift: RENAL ANGIOTENSIN II RECEPTOR FUNCTION IN OBESITY (R01 DK061578-07)

Name of Granting or Contracting Agency/Entity: National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Link: HHS
93.847

Program Title: none
CFDA Linked: Diabetes, Endocrinology and Metabolism Research

Note:

7R01DK061578-09 - Overall research plan has not changed from the original submission. As reported above, we have made and continue making timely progress in accomplishing the specific aims of the original research plan. Some of the research findings have been published, and a significant amount of research work has been translated into manuscripts which are either being reviewed or revised. In the next 2 years, we have planned to accomplish remaining parts of the specific aims originally ptoposed. The specific parts of the project to be accomplished are: (i) Kidney specific down-regulation of AT2R in Zucker rats, followed by treatment with AT2 agonist, telemetry blood pressure and renal function measurement, and (ii) Treatment of obese rats with rosiglitazone followed by examining the AT2R expression and function in proximal tubules.

Discussion: No discussion notes

 

Close Window